Skin Perfect debuts new line of supplements
BOONTON, N.J. — Skin Perfect makes its worldwide debut this month with a new line of natural health, beauty, and skin care supplements that are designed to deliver anti-aging benefits and healthy hair, skin, and nails. It is a natural offshoot of their sister company, Purity Select, which focuses on health and fitness products.
"We have leveraged Purity Select's expertise in scientifically formulated supplements and advanced ingredients to create a line of natural beauty and anti-aging products unlike any other on the market today," stated Daniel Levin, co-founder of Skin Perfect.
All Skin Perfect nutraceutical supplements are manufactured in the United States in Good Manufacturing Practice (GMP) facilities with multi-patented, clinically proven ingredients like Sensoril and Capros, plus high concentrations of other active ingredients and proprietary blends.
According to Levin, the new Skin Perfect supplements have received excellent reviews during preliminary product tests. For more information on Skin Perfect anti-aging and hair, skin, and nail supplements, visit SkinPerfect.net.
Camber adds new marketing, sales operations directors
PISCATAWAY, N.J. — Generics supplier Camber Pharmaceuticals added two new executives to its team this week, bringing on Kirk Hessels as marketing director and Amanda Rebnicky as its sales operations director.
“I am thrilled to add these two talented people to our organization,” Camber President Kon Ostaficiuk said. “Both Amanda and Kirk bring the type of energy, creativity and strategic thinking that will help Camber continue to grow as we add new products and meet the challenges of the generics marketplace.”
Hessels, who founded and spent 20 years at KH Advertising, leaves his most recent position as VP at marketing and graphic design firm Vision Creative Group to join Camber.
Rebnicky has previously worked with generics companies like Fougera Pharmaceuticals and Dr. Reddy Labs in sales and marketing roles.
Sanofi Pasteur starts shipping 2014 flu vaccine
SWIFTWATER, Pa. — The first batch of vaccines for the upcoming flu season is on its way to pharmacies, hospitals and doctors offices. Some 65 million doses Sanofi Pasteur’s Fluzone vaccines were approved for release earlier this week by the Food and Drug Administration.
“The flu impacts people in the U.S. every year, and the single best way to help prevent getting or spreading the influenza virus is timely vaccination,” said Sanofi Pasteur’s U.S. Chief Medical Officer and VP, scientific and medical affairs, David Greenberg. “Sanofi Pasteur is committed to helping people fight the flu by offering a broad range of flu vaccine options to meet the needs of patients across multiple age groups."
Though flu season isn’t typically in fever pitch until around February, the delivery schedule for vaccines continues through October for Sanofi Pasteur’s four Fluzone vaccines, the company said.
Beyond the traditional Fluzone, which is approved for children more than six months old, the company manufactured a vaccine that protects against four flu strains, as well as a high-dose vaccine for patients over 65 and an intradermal vaccine. The four-strain vaccine was first used last year, and the high-dose Fluzone is meant to strengthen immune systems more susceptible to catching the flu.
Sanofi Pasteur is still taking orders at VaccineShop.com from health providers.